Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 5417 - 5424 of 12092 results

Mintz Health Care Qui Tam Update - February 2019
February 20, 2019| Article| Viewpoint

The Bubbler - February 2019
February 19, 2019| Blog| Viewpoint

USCIS Announces More H-1Bs Eligible for Premium Processing
February 19, 2019| Alert| Viewpoint

2019 HSR Notification Thresholds Announced
February 19, 2019| Alert| Viewpoint

California Governor Floats “Data Dividend” Proposal
February 16, 2019| Blog| Viewpoint

New Justice Dept. policies, new AG may mute False Claims Act whistleblowers
February 16, 2019| News

Regulators Look to Increase Interoperability and Patient Access to Health Data
February 14, 2019| Blog| Viewpoint

Petition for Certiorari Asks Supreme Court to Clarify Whether the Federal Securities Laws Carry a Duty to Update
February 14, 2019| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
